Yükleniyor…
kapsadığımız 596 şirket, bunlardan 361 tanesi notlu
Buradaki her şirket aynı beş büyüme ve nakit üretimi kontrolünden geçirildi. Bu, sektörü bugün bildirdiği hâliyle anlatır — hangisinin alınacağını değil.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | $133,4B | $526,19 | 30,65 | $12,6B | %35,0 |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | $84,2B | $788,04 | 19,47 | $15,5B | %27,9 |
| MRNA | Moderna, Inc. | D- | $79,4B | $198,88 | — | $2,2B | -%141,4 |
| LGVN | LONGEVERON INC. | F- | $79B | $2,81 | — | $1,2M | -%1.977,6 |
| ARGX | ARGENX SE | notsuz | $59,4B | $959,49 | 49,03 | — | — |
| RVMD | Revolution Medicines, Inc. | F | $43,9B | $204,97 | — | $0,00 | — |
| ONC | BEONE MEDICINES LTD. | A+ | $41B | $360,85 | 64,55 | $6,1B | %10,7 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | A+ | $34,2B | $255,96 | 129,93 | $3,7B | %19,7 |
| RPRX | Royalty Pharma plc | B+ | $32,4B | $58,21 | 30,96 | $2,5B | %32,1 |
| NCNA | NUCANA PLC | notsuz | $26,6B | $1,28 | — | — | — |
| ROIV | ROIVANT SCIENCES LTD. | F- | $25,9B | $35,80 | — | $7,5M | -%3.535,0 |
| INSM | INSMED INC | C- | $25,7B | $117,83 | — | $1,1B | -%76,9 |
| INCY | INCYTE CORPORATION | A+ | $24,8B | $123,89 | 17,50 | $5,4B | %26,7 |
| BNTX | BioNTech SE | D | $24,7B | $98,52 | — | $3B | -%42,9 |
| JAZZ | Jazz Pharmaceuticals plc | A+ | $15,4B | $237,95 | 16,26 | $4,6B | %20,4 |
| AKTX | Akari Therapeutics, Plc | notsuz | $15,2B | $9,76 | — | — | — |
| EXEL | Exelixis Inc | A+ | $14,4B | $58,16 | 18,29 | $2,4B | %35,3 |
| ASND | Ascendis Pharma A/S | D | $14B | $225,60 | — | $1,2B | -%21,8 |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | $12,9B | $113,90 | 33,21 | $1,7B | %24,9 |
| BBIO | BridgeBio Pharma, Inc. | B | $12,8B | $65,57 | — | $713,1M | -%98,5 |
| CORT | CORCEPT THERAPEUTICS INC | C | $12,6B | $116,10 | 276,43 | $830,8M | %6,6 |
| SMMT | Summit Therapeutics Inc. | F | $12,5B | $15,61 | — | $0,00 | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | C- | $11,9B | $516,56 | — | $1,3B | -%25,3 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | A | $11,7B | $60,26 | 162,86 | $3,4B | %2,1 |
| TWST | Twist Bioscience Corporation | C- | $11,5B | $182,83 | — | $431,8M | -%31,7 |
| TECH | BIO-TECHNE Corp | B+ | $11,4B | $72,61 | 63,14 | $1,2B | %15,0 |
| KRYS | Krystal Biotech, Inc. | A+ | $10,2B | $345,82 | 43,34 | $440,5M | %54,8 |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | $10,2B | $195,09 | — | $776,6M | -%24,7 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | D- | $9,3B | $65,92 | — | $669,5M | -%47,8 |
| KYMR | KYMERA THERAPEUTICS, INC. | D- | $9,3B | $111,95 | — | $105M | -%285,3 |
| PTGX | Protagonist Therapeutics, Inc | A+ | $9,2B | $141,86 | 139,08 | $282M | %29,4 |
| CAI | CARIS LIFE SCIENCES, INC. | A+ | $9B | $31,98 | 18,92 | $989,6M | %10,6 |
| CYTK | CYTOKINETICS, INCORPORATED | F | $9B | $64,66 | — | $67,7M | -%1.321,1 |
| IBRX | IMMUNITYBIO, INC. | B | $8,9B | $8,44 | — | $165,8M | -%598,6 |
| TGTX | TG THERAPEUTICS, INC. | A+ | $8,8B | $57,43 | 20,88 | $799,5M | %55,2 |
| PCVX | VAXCYTE, INC. | notsuz | $8,4B | $56,21 | — | — | — |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | $7,8B | $280,78 | — | $0,00 | — |
| GPCR | Structure Therapeutics Inc. | notsuz | $7,7B | $35,93 | — | — | — |
| SYRE | SPYRE THERAPEUTICS, INC. | F | $7,6B | $85,69 | — | $0,00 | — |
| IONS | Ionis Pharmaceuticals, Inc. | F- | $7,4B | $44,50 | — | $874,1M | -%64,7 |
| ABVX | Abivax S.A. | notsuz | $7,2B | $91,06 | — | — | — |
| IMVT | IMMUNOVANT, INC. | notsuz | $6,9B | $33,30 | — | — | — |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | $6,8B | $98,66 | — | $239,9M | -%85,6 |
| BLTE | Belite Bio, Inc | notsuz | $6,6B | $167,33 | — | — | — |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | A+ | $6B | $301,52 | 32,04 | $290,5M | %67,9 |
| CGON | CG Oncology, Inc. | D- | $6B | $67,15 | — | $6,2M | -%3.602,7 |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F | $5,9B | $48,63 | — | $0,00 | — |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | $5,8B | $89,70 | — | $618,1M | -%139,2 |
| COGT | Cogent Biosciences, Inc. | notsuz | $5,6B | $32,31 | — | — | — |
| TVTX | TRAVERE THERAPEUTICS, INC. | D- | $5,6B | $59,44 | — | $591,3M | -%7,4 |
| ORKA | Oruka Therapeutics, Inc. | notsuz | $5,6B | $84,46 | — | — | — |
| GOSS | GOSSAMER BIO, INC. | B | $5,3B | $10,94 | — | $53,3M | -%235,0 |
| CRSP | CRISPR THERAPEUTICS AG | F- | $5,2B | $54,23 | — | $13,4M | -%3.368,7 |
| PTCT | PTC Therapeutics, Inc. | D | $5,2B | $62,67 | — | $1B | -%3,8 |
| ERAS | Erasca, Inc. | notsuz | $5B | $14,25 | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | $5B | $11,00 | — | $325M | -%89,1 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | F- | $5B | $88,55 | — | $2M | -%9.442,3 |
| MANE | Veradermics, Inc | notsuz | $4,9B | $116,57 | — | — | — |
| DFTX | Definium Therapeutics, Inc. | notsuz | $4,9B | $36,17 | — | — | — |
| EWTX | Edgewise Therapeutics, Inc. | notsuz | $4,3B | $39,34 | — | — | — |
| TNGX | Tango Therapeutics, Inc. | F- | $4,2B | $24,92 | — | $53,8M | -%229,9 |
| VKTX | Viking Therapeutics, Inc. | F | $4,1B | $35,56 | — | $0,00 | — |
| ABCL | AbCellera Biologics Inc. | D- | $3,9B | $12,70 | — | $66,2M | -%248,8 |
| CELC | CELCUITY INC. | notsuz | $3,9B | $79,52 | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D- | $3,9B | $11,45 | — | $803,8M | -%0,9 |
| RLAY | Relay Therapeutics, Inc. | C- | $3,8B | $17,47 | — | $10,4M | -%2.763,6 |
| XENE | XENON PHARMACEUTICALS INC. | F | $3,6B | $36,94 | — | $0,00 | — |
| ACAD | ACADIA PHARMACEUTICALS INC. | A+ | $3,6B | $20,68 | 9,27 | $1,1B | %33,4 |
| IDYA | IDEAYA Biosciences, Inc. | D- | $3,5B | $36,69 | — | $234,1M | -%74,8 |
| LEGN | Legend Biotech Corp | C- | $3,5B | $19,11 | — | $1B | -%24,6 |
| DBVT | DBV Technologies S.A. | F- | $3,4B | $11,56 | — | $5M | -%3.506,5 |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | A | $3,4B | $26,92 | 128,19 | $464M | %6,1 |
| TARS | TARSUS PHARMACEUTICALS, INC. | A | $3,3B | $75,69 | — | $606,3M | -%7,7 |
| ELVN | ENLIVEN THERAPEUTICS, INC. | notsuz | $3,3B | $44,75 | — | — | — |
| DNLI | Denali Therapeutics Inc. | F- | $3,3B | $20,39 | — | $3,6M | -%14.191,2 |
| RCUS | Arcus Biosciences, Inc. | D- | $3,2B | $24,97 | — | $117M | -%393,2 |
| DYN | Dyne Therapeutics, Inc. | notsuz | $3B | $16,03 | — | — | — |
| PGEN | PRECIGEN, INC. | F- | $2,8B | $7,75 | — | $9,7M | -%1.628,5 |
| NAMS | NewAmsterdam Pharma Company N.V. | F- | $2,7B | $22,58 | — | $7,1M | -%3.644,2 |
| MBX | MBX Biosciences, Inc. | notsuz | $2,6B | $53,63 | — | — | — |
| BEAM | Beam Therapeutics Inc. | C- | $2,5B | $24,27 | — | $156M | -%54,7 |
| IRON | Disc Medicine, Inc. | notsuz | $2,5B | $65,24 | — | — | — |
| CLDX | Celldex Therapeutics, Inc. | F- | $2,4B | $31,10 | — | $158K | -%190.220,9 |
| IMNM | Immunome, Inc. | F | $2,4B | $21,41 | — | $0,00 | — |
| QURE | uniQure N.V. | C- | $2,4B | $38,23 | — | $18,1M | -%1.154,4 |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | A+ | $2,4B | $41,26 | 13,35 | $959,9M | %18,9 |
| NRIX | NURIX THERAPEUTICS, INC. | F- | $2,4B | $23,01 | — | $36,8M | -%928,4 |
| VERA | Vera Therapeutics, Inc. | notsuz | $2,3B | $32,54 | — | — | — |
| SLS | SELLAS Life Sciences Group, Inc. | notsuz | $2,3B | $11,61 | — | — | — |
| VRDN | Viridian Therapeutics, Inc./DE | D- | $2,3B | $20,47 | — | $71,1M | -%544,1 |
| MLYS | MINERALYS THERAPEUTICS, INC. | notsuz | $2,3B | $25,86 | — | — | — |
| GMAB | Genmab A/S | A+ | $2,2B | $35,32 | 2,30 | $3,7B | %25,9 |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | $2,2B | $16,44 | 7,18 | $311,5M | %100,8 |
| OCUL | OCULAR THERAPEUTIX, INC | F- | $2,1B | $9,65 | — | $52,1M | -%579,1 |
| ADMA | ADMA BIOLOGICS, INC. | A+ | $2,1B | $9,38 | 13,40 | $512,3M | %33,0 |
| PHVS | Pharvaris N.V. | notsuz | $2,1B | $32,02 | — | — | — |
| TRVI | Trevi Therapeutics, Inc. | notsuz | $2,1B | $14,41 | — | — | — |
| VCEL | VERICEL CORPORATION | A | $2B | $39,71 | 84,49 | $306,3M | %7,9 |
| KOD | KODIAK SCIENCES INC. | notsuz | $2B | $32,35 | — | — | — |
| URGN | UroGen Pharma Ltd. | C | $2B | $41,35 | — | $188,7M | -%51,7 |
| NUVB | Nuvation Bio Inc. | C- | $2B | $5,74 | — | $169,9M | -%88,2 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | $2B | $3,74 | — | $54,9M | -%945,9 |
| PVLA | Palvella Therapeutics, Inc. | notsuz | $2B | $138,16 | — | — | — |
| SRPT | SAREPTA THERAPEUTICS, INC. | B- | $2B | $18,67 | — | $2B | -%6,9 |
| BHVN | Biohaven Ltd. | notsuz | $2B | $12,99 | — | — | — |
| MESO | MESOBLAST LIMITED | C- | $2B | $15,12 | — | $65,4M | -%156,2 |
| NKTR | Nektar Therapeutics | F- | $1,9B | $57,06 | — | $54,6M | -%287,8 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | $1,9B | $32,58 | — | $98,3M | -%418,2 |
| GENB | Generate Biomedicines, Inc. | notsuz | $1,9B | $15,15 | — | — | — |
| LKFT | GALAPAGOS NV | B | $1,9B | $29,38 | 5,30 | $1,3B | %28,9 |
| FTRE | FORTREA HOLDINGS INC. | C | $1,9B | $19,89 | — | $2,7B | -%3,2 |
| ZYME | ZYMEWORKS INC. | F- | $1,9B | $26,52 | — | $37,1M | -%404,0 |
| VIR | Vir Biotechnology, Inc. | C- | $1,8B | $10,66 | — | $303,2M | -%83,0 |
| XNCR | Xencor, Inc | F- | $1,8B | $23,80 | — | $105M | -%155,6 |
| SEPN | Septerna, Inc. | B | $1,8B | $37,77 | — | $98,9M | -%24,5 |
| ZBIO | Zenas BioPharma, Inc. | F- | $1,8B | $26,95 | — | $10M | -%4.843,8 |
| NVAX | NOVAVAX INC | D | $1,8B | $10,63 | — | $413,8M | -%59,9 |
| ABSI | ABSCI CORP | F- | $1,7B | $9,74 | — | $1,6M | -%7.756,4 |
| NTLA | INTELLIA THERAPEUTICS, INC. | C- | $1,6B | $11,75 | — | $59,5M | -%672,2 |
| RAPP | Rapport Therapeutics, Inc. | notsuz | $1,6B | $33,91 | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | $1,6B | $18,20 | — | $252,3M | -%87,5 |
| NBTX | Nanobiotix S.A. | C- | $1,6B | $33,31 | — | $37,1M | -%73,5 |
| STOK | Stoke Therapeutics, Inc. | F- | $1,6B | $24,80 | — | $27,6M | -%753,6 |
| IMCR | Immunocore Holdings plc | C- | $1,6B | $30,72 | — | $430,8M | -%4,2 |
| ANAB | ANAPTYSBIO, INC. | B+ | $1,5B | $51,00 | 8,89 | $237,6M | %82,4 |
| TSHA | Taysha Gene Therapies, Inc. | F- | $1,5B | $4,67 | — | $5,5M | -%2.728,0 |
| INVA | INNOVIVA, INC. | B+ | $1,5B | $20,74 | 5,05 | $440M | %81,2 |
| GHRS | GH Research PLC | notsuz | $1,5B | $23,84 | — | — | — |
| INBX | INHIBRX BIOSCIENCES, INC. | D- | $1,5B | $99,61 | — | $1,3M | -%10.629,3 |
| OMER | OMEROS CORP | notsuz | $1,5B | $20,08 | 11,67 | — | — |
| MAZE | MAZE THERAPEUTICS, INC. | F- | $1,4B | $26,05 | — | $167,5M | -%79,8 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | $1,4B | $14,50 | — | $717,2M | -%81,7 |
| AVBP | ARRIVENT BIOPHARMA, INC. | notsuz | $1,4B | $28,45 | — | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | F- | $1,4B | $14,86 | — | $85,6M | -%216,5 |
| ORIC | ORIC PHARMACEUTICALS, INC. | notsuz | $1,4B | $13,16 | — | — | — |
| JAGX | JAGUAR HEALTH, INC. | B | $1,3B | $7,70 | — | $27,8M | -%132,2 |
| TYRA | Tyra Biosciences, Inc. | notsuz | $1,3B | $21,76 | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | notsuz | $1,3B | $14,54 | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | notsuz | $1,3B | $20,66 | — | — | — |
| BCAX | Bicara Therapeutics Inc. | notsuz | $1,3B | $19,21 | — | — | — |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | notsuz | $1,2B | $34,42 | — | — | — |
| LBRX | LB Pharmaceuticals Inc | notsuz | $1,2B | $37,33 | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | notsuz | $1,2B | $12,36 | — | — | — |
| IMTX | Immatics N.V. | notsuz | $1,1B | $8,37 | — | — | — |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | $1,1B | $7,60 | — | $208,8M | -%37,1 |
| VOR | Vor Biopharma Inc. | notsuz | $1,1B | $18,52 | 0,10 | — | — |
| MNKD | MANNKIND CORP | C | $1,1B | $3,34 | — | $393,6M | -%11,1 |
| MGTX | MeiraGTx Holdings plc | A | $1B | $10,91 | 15,37 | $397,5M | %19,9 |
| ANRO | Alto Neuroscience, Inc. | notsuz | $1B | $26,49 | — | — | — |
| SVRA | Savara Inc | notsuz | $1B | $5,00 | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | notsuz | $1B | $12,04 | — | — | — |
| AKTS | Aktis Oncology, Inc. | notsuz | $1B | $19,43 | — | — | — |
| GLUE | Monte Rosa Therapeutics, Inc. | D- | $1B | $11,77 | — | $28,7M | -%560,8 |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | $1B | $14,47 | — | $92M | -%194,7 |
| JANX | Janux Therapeutics, Inc. | B- | $996,5M | $16,30 | — | $24M | -%427,5 |
| CRVS | Corvus Pharmaceuticals, Inc. | notsuz | $977,5M | $11,62 | — | — | — |
| ABUS | Arbutus Biopharma Corp | C+ | $959,6M | $4,85 | 6,14 | $181,7M | %84,2 |
| KURA | KURA ONCOLOGY, INC. | D- | $957,2M | $10,76 | — | $77,2M | -%384,3 |
| CGEM | CULLINAN THERAPEUTICS, INC. | notsuz | $953,1M | $14,81 | — | — | — |
| JBIO | Jade Biosciences, Inc. | notsuz | $917,1M | $14,42 | — | — | — |
| SGP | SpyGlass Pharma, Inc. | notsuz | $905,4M | $27,07 | — | — | — |
| RIGL | RIGEL PHARMACEUTICALS, INC. | B+ | $900M | $48,18 | 2,85 | $276,8M | %116,3 |
| ALMS | Alumis Inc. | D- | $897,3M | $7,10 | — | $7,4M | -%5.933,5 |
| TBPH | Theravance Biopharma, Inc. | B | $884,2M | $17,03 | 16,86 | $104,3M | %51,6 |
| SANA | Sana Biotechnology, Inc. | notsuz | $881,6M | $2,95 | — | — | — |
| APMD | Apnimed, Inc. | notsuz | $878M | $21,09 | — | — | — |
| ARDX | ARDELYX, INC. | B- | $852,2M | $3,42 | — | $450,9M | -%12,4 |
| CADL | CANDEL THERAPEUTICS, INC. | notsuz | $843,2M | $11,02 | — | — | — |
| AVTX | AVALO THERAPEUTICS, INC. | F- | $829,7M | $15,47 | — | $59K | -%170.055,9 |
| GYRE | Gyre Therapeutics, Inc. | D- | $819,6M | $7,35 | — | $119,4M | -%23,6 |
| GERN | GERON CORP | notsuz | $809,5M | $1,26 | — | — | — |
| LXRX | LEXICON PHARMACEUTICALS, INC. | C- | $798,7M | $1,80 | — | $41,5M | -%147,4 |
| IMMX | IMMIX BIOPHARMA, INC. | notsuz | $784,8M | $10,97 | — | — | — |
| SLDB | Solid Biosciences Inc. | notsuz | $781,7M | $7,29 | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | notsuz | $775,9M | $7,54 | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | notsuz | $765,6M | $8,75 | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | $758,5M | $12,12 | — | $0,00 | — |
| ACRS | Aclaris Therapeutics, Inc. | D- | $758,1M | $5,15 | — | $8,2M | -%921,5 |
| WVE | WAVE LIFE SCIENCES LTD. | F- | $744,8M | $3,78 | — | $42,7M | -%473,9 |
| PHAR | Pharming Group N.V. | A | $734M | $10,46 | 261,50 | $376,1M | %0,8 |
| ANNX | ANNEXON, INC. | notsuz | $719,3M | $3,64 | — | — | — |
| VSTM | Verastem, Inc. | D- | $701M | $7,74 | — | $87,5M | -%231,6 |
| MDXG | MiMedx Group, Inc. | C | $680,7M | $4,67 | 116,75 | $355,2M | %1,8 |
| OABI | OMNIAB, INC. | D- | $670,2M | $4,61 | — | $38,5M | -%115,1 |
| CLYM | CLIMB BIO, INC. | notsuz | $669,7M | $11,66 | — | — | — |
| NVCT | Nuvectis Pharma, Inc. | notsuz | $658,8M | $20,22 | — | — | — |
| ZVRA | Zevra Therapeutics, Inc. | A+ | $655,6M | $11,04 | 12,00 | $136,1M | %42,8 |
| IVA | Inventiva S.A. | F | $651,2M | $3,37 | — | $5,1M | -%7.899,6 |
| AURA | Aura Biosciences, Inc. | notsuz | $622,2M | $6,00 | — | — | — |
| IBO | Impact BioMedical, INC. | A | $613,5M | $5,69 | 6,47 | $35K | %2.254,3 |
| CRMD | CORMEDIX INC. | A+ | $611,9M | $7,85 | 3,83 | $462,2M | %40,5 |
| STTK | Shattuck Labs, Inc. | C- | $609,2M | $6,07 | — | $1M | -%5.256,8 |
| ALT | ALTIMMUNE, INC. | D- | $595,2M | $3,06 | — | $41K | -%223.804,9 |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | D- | $591,2M | $10,66 | — | $111,9M | -%260,0 |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | $590,6M | $7,30 | — | $239,7M | -%41,3 |
| CTMX | CytomX Therapeutics, Inc. | F- | $588,3M | $2,70 | — | $18,3M | -%435,2 |
| MNPR | Monopar Therapeutics Inc. | F | $572,1M | $85,24 | — | $0,00 | — |
| ALLO | Allogene Therapeutics, Inc. | B- | $570,1M | $1,65 | — | $6,8M | -%2.419,5 |
| NGNE | Neurogene Inc. | F | $566,5M | $28,31 | — | $0,00 | — |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | notsuz | $545,6M | $2,57 | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | notsuz | $542,3M | $34,74 | — | — | — |
| VALN | Valneva SE | D- | $532,8M | $6,14 | — | $177,9M | -%73,7 |
| SLN | Silence Therapeutics plc | C- | $528,2M | $11,18 | — | $615K | -%9.748,5 |
| PRME | Prime Medicine, Inc. | C- | $526M | $2,90 | — | $4,6M | -%4.056,4 |
| CBIO | CRESCENT BIOPHARMA, INC. | D- | $519,6M | $13,99 | — | $10,8M | -%885,5 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | $504,3M | $9,77 | 18,79 | $231,2M | %11,6 |
| ANL | Adlai Nortye Ltd. | C | $496,6M | $15,53 | — | $5M | -%710,6 |
| ARVN | ARVINAS, INC. | B | $496,3M | $7,59 | 31,63 | $316,7M | %2,9 |
| AUTL | Autolus Therapeutics plc | C- | $493,7M | $1,86 | — | $117,4M | -%238,7 |
| RGNX | REGENXBIO Inc. | D- | $488,5M | $7,40 | — | $174,5M | -%112,6 |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | $486M | $8,36 | — | $0,00 | — |
| PBLS | Parabilis Medicines, Inc. | notsuz | $485,3M | $31,20 | — | — | — |
| OCS | Oculis Holding AG | notsuz | $484,3M | $9,27 | — | — | — |
| ASMB | Assembly Biosciences, Inc. | B- | $481,9M | $23,67 | 23,21 | $72,3M | -%0,1 |
| TECX | TECTONIC THERAPEUTIC, INC. | notsuz | $462,7M | $23,67 | — | — | — |
| MPLT | MapLight Therapeutics, Inc. | notsuz | $443,9M | $10,46 | — | — | — |
| AVLN | Avalyn Pharma Inc. | notsuz | $435,8M | $28,08 | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | notsuz | $429M | $7,92 | — | — | — |
| DMAC | DiaMedica Therapeutics Inc. | notsuz | $428,2M | $7,94 | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | C- | $425,6M | $8,29 | — | $54,5M | -%80,7 |
| KYTX | Kyverna Therapeutics, Inc. | notsuz | $421,2M | $6,81 | — | — | — |
| AVIR | Atea Pharmaceuticals, Inc. | notsuz | $414,7M | $5,17 | — | — | — |
| SPTX | Seaport Therapeutics, Inc. | notsuz | $411,4M | $21,52 | — | — | — |
| RLMD | RELMADA THERAPEUTICS, INC. | notsuz | $408,5M | $3,83 | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | D- | $405,7M | $4,08 | — | $116,9M | -%184,2 |
| YDES | YD Bio Limited | D | $405,6M | $5,73 | — | $596,8K | -%1.392,6 |
| SGMT | Sagimet Biosciences Inc. | notsuz | $396,3M | $9,24 | — | — | — |
| EDIT | EDITAS MEDICINE, INC. | B- | $396,2M | $2,58 | — | $47M | -%157,3 |
| IRD | Opus Genetics, Inc. | F- | $396M | $4,76 | — | $9,9M | -%1.091,8 |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | $393,7M | $13,85 | — | $29,4M | -%317,6 |
| GALT | GALECTIN THERAPEUTICS INC. | notsuz | $393,3M | $3,90 | — | — | — |
| ZURA | ZURA BIO LIMITED | notsuz | $387,1M | $4,04 | — | — | — |
| AGEN | AGENUS INC | C | $384,5M | $8,54 | 3,31 | $132,7M | %69,3 |
| RZLT | REZOLUTE, INC. | notsuz | $377,2M | $3,90 | — | — | — |
| TTRX | Turn Therapeutics Inc. | notsuz | $372,1M | $12,49 | — | — | — |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | $371,9M | $10,61 | — | $59,2M | -%5,5 |
| ODTX | Odyssey Therapeutics, Inc. | notsuz | $369,9M | $20,51 | — | — | — |
| CCCC | C4 Therapeutics, Inc. | C- | $366,6M | $2,98 | — | $35M | -%289,4 |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | $357,6M | $5,95 | — | $32M | -%184,6 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | notsuz | $356,3M | $51,80 | — | — | — |
| CABA | CABALETTA BIO, INC. | notsuz | $351M | $2,07 | — | — | — |
| SRZN | Surrozen, Inc./DE | D | $347,2M | $29,54 | — | $11,5M | -%2.885,3 |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | $346M | $11,88 | — | $65,3M | -%96,9 |
| OCGN | OCUGEN, INC. | C | $345,9M | $1,02 | — | $4,6M | -%1.786,3 |
| ARTV | Artiva Biotherapeutics, Inc. | F- | $341,7M | $6,99 | — | $0,00 | — |
| IMUX | Immunic, Inc. | notsuz | $339,8M | $9,35 | — | — | — |
| BNTC | Benitec Biopharma Inc. | D | $334,5M | $9,59 | — | $0,00 | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | notsuz | $319,4M | $3,08 | — | — | — |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | notsuz | $316,7M | $3,95 | — | — | — |
| VERU | VERU INC. | notsuz | $313,4M | $2,54 | — | — | — |
| EYPT | EyePoint, Inc. | F- | $312,1M | $3,62 | — | $2,8M | -%10.994,7 |
| GTBP | GT BIOPHARMA, INC. | notsuz | $310,8M | $6,89 | 18,61 | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | $309,2M | $3,88 | — | $22,4M | -%269,7 |
| ABEO | ABEONA THERAPEUTICS INC. | C- | $308,8M | $5,40 | — | $25,5M | -%246,4 |
| EVMN | Evommune, Inc. | D- | $308,1M | $8,49 | — | $10M | -%946,7 |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | $305,3M | $5,05 | — | $215,7M | -%127,4 |
| IPSC | Century Therapeutics, Inc. | B- | $302,4M | $1,67 | — | $109,2M | -%100,6 |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | $299,3M | $3,29 | — | $0,00 | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | $298,4M | $3,01 | — | $15,8M | -%568,8 |
| KARD | Kardigan, Inc. | notsuz | $294,3M | $14,79 | — | — | — |
| UPB | UPSTREAM BIO, INC. | D- | $293,6M | $5,36 | — | $3,2M | -%4.955,7 |
| CTNM | Contineum Therapeutics, Inc. | D | $290,1M | $12,56 | — | $0,00 | — |
| IKT | Inhibikase Therapeutics, Inc. | F | $287,4M | $2,06 | — | $0,00 | — |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | $285,5M | $8,01 | — | $0,00 | — |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | $285,4M | $3,74 | — | $0,00 | — |
| RCKT | Rocket Pharmaceuticals, Inc. | D | $284,9M | $2,60 | — | $0,00 | — |
| LIMN | LIMINATUS PHARMA, INC. | notsuz | $281,7M | $4,20 | — | — | — |
| FATE | FATE THERAPEUTICS INC | D- | $281,6M | $2,35 | — | $6,5M | -%1.941,1 |
| IMRX | Immuneering Corporation | notsuz | $276,2M | $4,27 | — | — | — |
| IVVD | INVIVYD, INC. | C- | $275,4M | $0,93 | — | $58,4M | -%183,9 |
| HELP | CYBIN INC. | notsuz | $272,4M | $12,61 | — | — | — |
| LXEO | Lexeo Therapeutics, Inc. | notsuz | $271,6M | $3,31 | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | notsuz | $267,4M | $18,22 | — | — | — |
| STRO | SUTRO BIOPHARMA, INC. | F | $265M | $15,98 | — | $45,7M | -%395,2 |
| QTTB | Q32 Bio Inc. | B | $261,1M | $8,77 | 2,80 | $53,7M | %62,9 |
| LCTX | Lineage Cell Therapeutics, Inc. | D- | $260,5M | $1,03 | — | $13,1M | -%246,6 |
| BCYC | Bicycle Therapeutics plc | D- | $257M | $3,69 | — | $61,2M | -%311,1 |
| ACIU | AC IMMUNE SA | F- | $256,4M | $2,52 | — | $4,3M | -%1.207,8 |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | $254M | $12,86 | — | $0,00 | — |
| PALI | PALISADE BIO, INC. | C- | $252,7M | $1,45 | — | $500K | -%6.388,2 |
| INDP | Indaptus Therapeutics, Inc. | notsuz | $246,8M | $3,85 | — | — | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | $246M | $3,92 | — | $3,5M | -%3.065,9 |
| LYEL | Lyell Immunopharma, Inc. | D- | $241,4M | $9,85 | — | $27K | -%920.285,2 |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | $239,8M | $6,16 | — | $4,7M | -%3.537,7 |
| PYXS | Pyxis Oncology, Inc. | D- | $238,5M | $2,86 | — | $13,9M | -%640,3 |
| MGNX | MACROGENICS, INC. | C- | $238,2M | $3,74 | — | $167,7M | -%8,7 |
| SION | SIONNA THERAPEUTICS, INC. | notsuz | $236,5M | $5,23 | — | — | — |
| KROS | Keros Therapeutics, Inc. | D- | $230,4M | $11,62 | — | $15M | -%553,9 |
| CUE | Cue Biopharma, Inc. | D- | $228,2M | $31,41 | — | $37,7M | -%435,8 |
| NRSN | NeuroSense Therapeutics Ltd. | notsuz | $226,3M | $6,95 | — | — | — |
| CGEN | COMPUGEN LTD | B+ | $225M | $2,38 | 6,26 | $74M | %47,6 |
| RNAC | Cartesian Therapeutics, Inc. | F | $224,2M | $7,41 | — | $1,5M | -%10.283,8 |
| ZLAB | ZAI LAB LIMITED | C- | $221,3M | $24,98 | — | $449,6M | -%41,9 |
| AVXL | ANAVEX LIFE SCIENCES CORP. | notsuz | $220,6M | $2,38 | — | — | — |
| PLX | Protalix BioTherapeutics, Inc. | A+ | $219,2M | $2,72 | 11,83 | $80,6M | %23,5 |
| ALEC | Alector, Inc. | D- | $217,7M | $1,95 | — | $13,9M | -%850,1 |
| MLEC | MOOLEC SCIENCE SA | D | $217,4M | $5,60 | — | $333,6M | -%52,9 |
| ELDN | Eledon Pharmaceuticals, Inc. | notsuz | $215,3M | $2,65 | — | — | — |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | $213,2M | $3,74 | — | $0,00 | — |
| FHTX | Foghorn Therapeutics Inc. | B | $207,8M | $3,50 | — | $36,7M | -%175,8 |
| CMPX | COMPASS THERAPEUTICS, INC. | F | $203,5M | $1,13 | — | $0,00 | — |
| NKTX | Nkarta, Inc. | D | $197M | $2,75 | — | $0,00 | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | $196,8M | $4,73 | 1,15 | $2M | %8.743,5 |
| TARA | Protara Therapeutics, Inc. | notsuz | $193,8M | $3,28 | — | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | $193,5M | $2,70 | — | $0,00 | — |
| SLGL | Sol-Gel Technologies Ltd. | B | $186,3M | $66,85 | — | $1,8M | -%341,3 |
| ACOG | Alpha Cognition Inc. | D- | $184,5M | $8,47 | — | $15,3M | -%153,6 |
| ANTX | AN2 Therapeutics, Inc. | notsuz | $184,2M | $4,88 | — | — | — |
| ALXO | ALX ONCOLOGY HOLDINGS INC | notsuz | $181,1M | $1,31 | — | — | — |
| PEPG | PEPGEN INC. | notsuz | $179,4M | $2,59 | — | — | — |
| MDWD | MEDIWOUND LTD. | F- | $177,6M | $13,84 | — | $11,9M | -%170,1 |
| CHRS | Coherus Oncology, Inc. | B | $174,6M | $1,13 | — | $50,9M | -%259,4 |
| PRQR | ProQR Therapeutics N.V. | C- | $173,8M | $1,65 | — | $20,9M | -%229,7 |
| MOLN | MOLECULAR PARTNERS AG | F- | $173,6M | $4,30 | — | $5,2M | -%1.437,4 |
| ADAG | Adagene Inc. | C- | $173,5M | $2,93 | — | $7,7M | -%229,6 |
| DTIL | PRECISION BIOSCIENCES INC | D- | $171,7M | $6,22 | — | $45,1M | -%117,0 |
| OVID | Ovid Therapeutics Inc. | C- | $170,1M | $2,40 | — | $1,6M | -%2.178,9 |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | $169,1M | $9,86 | — | $29,1M | -%548,6 |
| VYGR | Voyager Therapeutics, Inc. | F- | $165,1M | $2,68 | — | $34,5M | -%312,6 |
| NERV | Minerva Neurosciences, Inc. | F | $162,3M | $3,40 | — | $0,00 | — |
| ABOS | Acumen Pharmaceuticals, Inc. | notsuz | $162M | $2,24 | — | — | — |
| IPHA | Innate Pharma SA | F- | $159,3M | $1,70 | — | $10,2M | -%546,1 |
| NBP | NovaBridge Biosciences | notsuz | $159,2M | $1,38 | — | — | — |
| HUMA | Humacyte, Inc. | C- | $154,8M | $0,56 | — | $2,1M | -%4.560,8 |
| NGEN | NERVGEN PHARMA CORP. | notsuz | $154,5M | $1,94 | — | — | — |
| MENS | Jyong Biotech Ltd. | notsuz | $154,3M | $2,03 | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | notsuz | $148,7M | $4,74 | — | — | — |
| CLLS | Cellectis S.A. | C- | $147,4M | $1,47 | — | $72,9M | -%92,7 |
| BRVE | Braveheart Bio, Inc. | notsuz | $147,1M | $20,62 | — | — | — |
| KRSA | CYCLERION THERAPEUTICS, INC. | F- | $145,1M | $31,00 | — | $1,9M | -%353,0 |
| CDXS | Codexis, Inc. | D- | $144,5M | $1,32 | — | $77,7M | -%39,6 |
| RNA | Atrium Therapeutics, Inc. | notsuz | $141,8M | $8,29 | — | — | — |
| KRRO | Korro Bio, Inc. | C- | $140,9M | $9,57 | — | $2,4M | -%4.477,1 |
| SPRB | Spruce Biosciences, Inc. | F | $140M | $48,72 | — | $0,00 | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | notsuz | $139,1M | $3,74 | — | — | — |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | notsuz | $138,1M | $7,14 | — | — | — |
| TNYA | Tenaya Therapeutics, Inc. | notsuz | $136,7M | $0,61 | — | — | — |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | $136,7M | $0,76 | — | $4,9M | -%618,0 |
| IFRX | InflaRx N.V. | F- | $136,6M | $1,89 | — | $33,4K | -%155.582,1 |
| ENTX | ENTERA BIO LTD. | F | $134,8M | $2,75 | — | $0,00 | — |
| MSLE | Satellos Bioscience Inc. | notsuz | $134,5M | $8,70 | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | $133,8M | $2,10 | — | $0,00 | — |
| CRBU | Caribou Biosciences, Inc. | D- | $132,9M | $1,24 | — | $10M | -%1.030,4 |
| ENGN | enGene Therapeutics Inc. | notsuz | $131,4M | $1,96 | — | — | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | notsuz | $130,8M | $4,70 | — | — | — |
| NMRA | NEUMORA THERAPEUTICS, INC. | notsuz | $127,3M | $0,68 | — | — | — |
| MNOV | MEDICINOVA, INC. | C- | $127M | $2,58 | — | $920,5K | -%1.168,2 |
| VOGX | Vogenx, Inc. | notsuz | $123,9M | $22,73 | — | — | — |
| LENZ | LENZ THERAPEUTICS, INC. | D- | $123M | $3,92 | — | $19,1M | -%660,1 |
| NAUT | Nautilus Biotechnology, Inc. | notsuz | $122,5M | $0,96 | — | — | — |
| INO | INOVIO PHARMACEUTICALS, INC. | D | $122M | $1,18 | — | $0,00 | — |
| TLSA | Tiziana Life Sciences Ltd | notsuz | $121,7M | $1,01 | — | — | — |
| COYA | Coya Therapeutics, Inc. | F- | $119,2M | $5,08 | — | $8M | -%270,2 |
| OKUR | ONKURE THERAPEUTICS, INC. | C | $117,4M | $2,90 | — | $0,00 | — |
| GNLX | GENELUX CORPORATION | F- | $112,2M | $2,48 | — | $8K | -%444.950,0 |
| VANI | Vivani Medical, Inc. | F | $111,9M | $1,24 | — | $0,00 | — |
| AARD | AARDVARK THERAPEUTICS, INC. | F | $110,7M | $5,06 | — | $0,00 | — |
| CNXU | CONEXEU SCIENCES INC. | notsuz | $109,7M | $3,89 | — | — | — |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | D | $108M | $1,88 | — | $0,00 | — |
| EQ | EQUILLIUM, INC. | C- | $105,9M | $1,67 | — | $41,1M | -%43,8 |
| SEER | SEER, INC. | D- | $105,8M | $1,91 | — | $14,2M | -%478,0 |
| PLYX | Polaryx Therapeutics, Inc. | notsuz | $104,2M | $2,09 | — | — | — |
| QNCX | Quince Therapeutics, Inc. | notsuz | $102,2M | $31,00 | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | notsuz | $101,1M | $11,27 | — | — | — |
| PROK | ProKidney Corp. | F- | $98,5M | $1,60 | — | $818K | -%10.288,4 |
| MIST | Milestone Pharmaceuticals Inc. | notsuz | $98,2M | $0,79 | — | — | — |
| FTH | Faeth Therapeutics, Inc. | notsuz | $97,5M | $28,00 | — | — | — |
| NTRB | NUTRIBAND INC. | F- | $97,2M | $8,00 | — | $1,6M | -%430,4 |
| ANIX | ANIXA BIOSCIENCES, INC. | notsuz | $96,6M | $2,78 | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | $96,5M | $1,24 | — | $508K | -%7.884,1 |
| BMEA | Biomea Fusion, Inc. | notsuz | $95,7M | $1,32 | — | — | — |
| PYPD | PolyPid Ltd | notsuz | $95M | $5,22 | 2,50 | — | — |
| NRXS | NEURAXIS, INC. | D- | $94,9M | $7,56 | — | $5,3M | -%144,4 |
| ICCC | ImmuCell Corporation | A | $90,1M | $9,93 | 141,79 | $30,7M | %2,6 |
| ACRV | Acrivon Therapeutics, Inc. | notsuz | $90M | $2,10 | — | — | — |
| CGTX | Cognition Therapeutics, Inc. | notsuz | $89,1M | $0,94 | — | — | — |
| ATRA | ATARA BIOTHERAPEUTICS, INC. | D | $88,4M | $8,81 | — | $6,2M | -%269,4 |
| RLYB | RALLYBIO CORPORATION | D | $88,3M | $16,62 | 3,38 | $646K | %7.051,2 |
| ONCY | ONCOLYTICS BIOTECH INC. | notsuz | $87,1M | $0,68 | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | $85,8M | $3,31 | — | $40K | -%118.029,5 |
| PTHS | Pelthos Therapeutics Inc. | C- | $85M | $22,19 | — | $50,4M | -%171,4 |
| TELO | Telomir Pharmaceuticals, Inc. | notsuz | $84,6M | $1,23 | — | — | — |
| ACET | Adicet Bio, Inc. | notsuz | $84,4M | $9,02 | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | $84,4M | $2,28 | 0,86 | $68,5M | %163,3 |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | $81,3M | $3,28 | — | $194K | -%3.985,6 |
| GANX | GAIN THERAPEUTICS, INC | notsuz | $77,7M | $1,78 | — | — | — |
| GUTS | Fractyl Health, Inc. | F- | $77,3M | $0,49 | — | $0,00 | — |
| OSTX | OS THERAPIES INCORPORATED | notsuz | $76,6M | $1,66 | — | — | — |
| IBIO | IBIO, INC. | D- | $76,5M | $1,19 | — | $100K | -%33.044,0 |
| VRCA | Verrica Pharmaceuticals Inc. | C- | $75,1M | $4,37 | — | $30,3M | -%102,8 |
| RNXT | RENOVORX, INC. | D- | $74,9M | $1,66 | — | $2M | -%621,7 |
| ATTO | Attovia Therapeutics, Inc. | notsuz | $74,6M | $17,78 | — | — | — |
| BSEM | BioStem Technologies, Inc. | D- | $73,9M | $4,14 | — | $34,6M | -%81,8 |
| MAIA | MAIA Biotechnology, Inc. | F | $73M | $1,20 | — | $0,00 | — |
| ALDX | ALDEYRA THERAPEUTICS, INC. | notsuz | $72,7M | $1,21 | — | — | — |
| OKYO | OKYO Pharma Limited | notsuz | $72,4M | $1,38 | — | — | — |
| SPRO | Spero Therapeutics, Inc. | C | $71,6M | $1,23 | 8,79 | $47M | %15,7 |
| PMVP | PMV PHARMACEUTICALS, INC. | notsuz | $71,1M | $1,33 | — | — | — |
| CING | Cingulate Inc. | notsuz | $70,2M | $4,83 | — | — | — |
| LNAI | Lunai Bioworks Inc. | notsuz | $70M | $1,93 | — | — | — |
| LONA | LeonaBio, Inc. | notsuz | $69,5M | $3,25 | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | notsuz | $69,5M | $2,92 | — | — | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | $68,2M | $4,90 | — | $60,7M | -%1,8 |
| CNTB | Connect Biopharma Holdings Limited | C- | $68M | $1,08 | — | $3M | -%2.336,3 |
| TENX | TENAX THERAPEUTICS, INC. | F | $67,7M | $1,81 | — | $0,00 | — |
| PLRX | PLIANT THERAPEUTICS, INC. | D | $66,9M | $1,08 | — | $0,00 | — |
| XBIT | XBIOTECH INC. | notsuz | $66,2M | $2,17 | — | — | — |
| ALPS | ALPS GROUP INC | notsuz | $65,9M | $0,40 | — | — | — |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | $65M | $2,55 | — | $357,9K | -%3.089,6 |
| RNTX | Rein Therapeutics, Inc. | F | $64,6M | $0,75 | — | $0,00 | — |
| HYFT | MindWalk Holdings Corp. | C- | $64,5M | $1,38 | — | $19,8M | -%43,6 |
| HYPD | HYPERION DEFI, INC. | D+ | $62,8M | $4,04 | — | $1,4M | %474,9 |
| INKT | MiNK Therapeutics, Inc. | notsuz | $62,2M | $12,18 | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | $60,7M | $15,03 | — | $0,00 | — |
| BOLD | BOUNDLESS BIO, INC. | notsuz | $60,5M | $2,66 | — | — | — |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | $59,6M | $0,64 | — | -$1,2M | %5.253,5 |
| SKYE | Skye Bioscience, Inc. | notsuz | $59,2M | $1,67 | — | — | — |
| MREO | MEREO BIOPHARMA GROUP PLC | B | $59,1M | $0,37 | — | $500K | -%5.619,8 |
| EXOZ | EXOZYMES INC. | notsuz | $58M | $6,25 | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | D- | $57,4M | $5,51 | — | $3,7M | -%2.031,1 |
| INMB | INMUNE BIO INC. | D- | $56,3M | $2,03 | — | $50K | -%36.832,0 |
| BCAB | BIOATLA, INC. | notsuz | $56,1M | $1,74 | — | — | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | C- | $55,9M | $0,29 | — | $151,2M | -%22,5 |
| ANVS | Annovis Bio, Inc. | F | $55,8M | $1,31 | — | $0,00 | — |
| CLNN | Clene Inc. | D | $55,2M | $4,30 | — | $197K | -%20.059,9 |
| CLGN | CollPlant Biotechnologies Ltd | B- | $54,4M | $4,25 | — | $2,4M | -%484,6 |
| IMA | ImageneBio, Inc. | D- | $53,6M | $4,72 | — | $800K | -%6.560,5 |
| SER | Serina Therapeutics, Inc. | D | $53,1M | $2,09 | — | $130K | -%16.288,5 |
| SCTX | SCRIBE THERAPEUTICS INC. | notsuz | $52,5M | $21,28 | — | — | — |
| XLO | Xilio Therapeutics, Inc. | C- | $52,3M | $9,04 | — | $64,1M | -%34,1 |
| BLSM | BlossomHill Therapeutics, Inc. | notsuz | $52,3M | $19,75 | — | — | — |
| LITS | Lite Strategy, Inc. | D | $49M | $1,44 | — | $0,00 | — |
| TIL | Instil Bio, Inc. | C- | $48,6M | $7,17 | — | $9M | -%337,7 |
| ELTX | Elicio Therapeutics, Inc. | notsuz | $48,4M | $1,84 | — | — | — |
| TVGN | Tevogen Inc. | notsuz | $47,2M | $7,25 | — | — | — |
| HOWL | WEREWOLF THERAPEUTICS, INC. | notsuz | $46,7M | $0,96 | — | — | — |
| DWTX | Dogwood Therapeutics, Inc. | notsuz | $46,2M | $1,36 | — | — | — |
| PDSB | PDS Biotechnology Corp | notsuz | $44,6M | $0,80 | — | — | — |
| GRCE | Grace Therapeutics, Inc. | notsuz | $44,6M | $2,12 | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | $44,2M | $0,34 | — | $7,1M | -%1.655,4 |
| MGX | Metagenomi Therapeutics, Inc. | D- | $43,4M | $1,15 | — | $22,3M | -%418,5 |
| KAPA | KAIROS PHARMA, LTD. | notsuz | $40,8M | $1,72 | — | — | — |
| CELU | Celularity Inc. | C | $39,9M | $1,38 | — | $26,6M | -%345,4 |
| ATHE | ALTERITY THERAPEUTICS LTD | notsuz | $39,1M | $3,67 | — | — | — |
| EDSA | EDESA BIOTECH, INC. | notsuz | $38,7M | $4,01 | — | — | — |
| IMMP | Immutep Limited | D- | $38,5M | $0,26 | — | $7,3M | -%594,6 |
| CRVO | CervoMed Inc. | F- | $38,4M | $2,54 | — | $331,3K | -%9.160,9 |
| ATNM | ACTINIUM PHARMACEUTICALS, INC. | D+ | $37,7M | $1,20 | 3,33 | $90K | %12.564,4 |
| ELAB | PMGC HOLDINGS INC. | D- | $37M | $4,57 | — | $2,6M | -%523,0 |
| FLNA | Filana Therapeutics, Inc. | notsuz | $36,1M | $0,75 | — | — | — |
| NIKI | Niki BioSolutions, Inc. | notsuz | $35M | $4,76 | — | — | — |
| MCRB | Seres Therapeutics, Inc. | D- | $35M | $3,52 | — | $1,9M | -%1.192,9 |
| ICU | SeaStar Medical Holding Corp | D- | $34,1M | $3,42 | — | $1,7M | -%795,5 |
| BYSI | BeyondSpring Inc. | D | $32M | $0,78 | — | $0,00 | — |
| CNTX | CONTEXT THERAPEUTICS INC. | notsuz | $31,8M | $0,35 | — | — | — |
| NNVC | NANOVIRICIDES, INC. | F | $31,2M | $1,44 | — | $0,00 | — |
| ABVC | ABVC BioPharma, Inc. | D- | $30,1M | $1,13 | — | $296K | -%2.400,9 |
| ATYR | aTYR PHARMA INC | F- | $29,9M | $0,31 | — | $190K | -%32.003,7 |
| CVM | CEL-SCI CORPORATION | notsuz | $29,4M | $1,67 | — | — | — |
| IGC | IGC PHARMA, INC. | C- | $29,2M | $0,28 | — | $1,3M | -%560,3 |
| ENLV | Enlivex Ltd. | notsuz | $29M | $0,60 | 0,02 | — | — |
| CALC | CalciMedica, Inc. | notsuz | $28,8M | $1,75 | — | — | — |
| KYNB | KYNTRA BIO, INC. | F | $28,1M | $6,94 | 0,15 | $4,6M | %3.967,8 |
| EVAX | Evaxion A/S | B- | $27,9M | $3,34 | — | $7,5M | -%102,4 |
| NRXP | NRX Pharmaceuticals, Inc. | B | $26,5M | $3,00 | — | $3,4M | -%691,8 |
| APRE | Aprea Therapeutics, Inc. | notsuz | $26M | $0,76 | — | — | — |
| APLM | Apollomics Inc. | B | $24,7M | $22,35 | — | $8,5M | -%128,7 |
| GRDX | GRIDAI TECHNOLOGIES CORP | F- | $24,5M | $3,43 | — | $36,3K | -%56.864,0 |
| NXTC | NEXTCURE, INC | notsuz | $23,3M | $5,08 | — | — | — |
| COCP | COCRYSTAL PHARMA, INC. | notsuz | $22,5M | $1,17 | — | — | — |
| YARW | YARROW BIOSCIENCE, INC. | C- | $21,9M | $25,54 | — | $570K | -%4.646,1 |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | notsuz | $20,9M | $0,48 | — | — | — |
| JSPR | JASPER THERAPEUTICS, INC. | notsuz | $20,3M | $0,61 | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | $19,2M | $1,15 | — | $3,9M | -%220,5 |
| ATOS | ATOSSA THERAPEUTICS, INC. | notsuz | $19M | $1,90 | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | notsuz | $18,6M | $4,93 | — | — | — |
| PTN | PALATIN TECHNOLOGIES, INC. | B | $18M | $10,10 | — | $12,9M | -%48,6 |
| LPCN | LIPOCINE INC. | C- | $17,3M | $2,10 | — | $1,6M | -%755,1 |
| BCTX | BRIACELL THERAPEUTICS CORP. | notsuz | $17M | $4,32 | — | — | — |
| CLRB | Cellectar Biosciences, Inc. | notsuz | $17M | $1,80 | — | — | — |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | $16,9M | $1,27 | — | $7,6M | -%344,2 |
| KTTA | PASITHEA THERAPEUTICS CORP. | notsuz | $16,7M | $0,50 | — | — | — |
| ACTU | Actuate Therapeutics, Inc. | notsuz | $16,3M | $0,68 | — | — | — |
| BCDA | BioCardia, Inc. | F | $15,9M | $1,05 | — | $0,00 | — |
| CTXR | Citius Pharmaceuticals, Inc. | notsuz | $15,9M | $0,58 | — | — | — |
| LTGO | Latigo Biotherapeutics, Inc. | notsuz | $15,8M | $17,15 | — | — | — |
| LTRN | Lantern Pharma Inc. | notsuz | $15,6M | $1,22 | — | — | — |
| CMMB | SNOWDRIFT PARENT CORPORATION | notsuz | $15,5M | $2,16 | 120,00 | — | — |
| KZIA | Kazia Therapeutics Limited. | F | $15,5M | $9,57 | 8,43 | $29,5K | -%54.287,3 |
| PASG | PASSAGE BIO, INC. | notsuz | $15,4M | $4,80 | — | — | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | $15,2M | $0,42 | — | $3,8M | -%200,5 |
| CNSY | CERENOME, INC. | F- | $15,1M | $1,99 | — | $4,2M | -%620,7 |
| HIND | VYOME HOLDINGS, INC. | F- | $14,3M | $2,04 | — | $129,7K | -%8.716,8 |
| LSTA | LISATA THERAPEUTICS, INC. | C- | $14,2M | $1,58 | — | $100K | -%14.621,0 |
| NCEL | NewcelX Ltd. | notsuz | $14,1M | $2,95 | 1,36 | — | — |
| AEON | AEON Biopharma, Inc. | notsuz | $13,1M | $0,26 | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | $13M | $1,65 | — | $3,6M | -%1.055,3 |
| PLUR | Pluri Inc. | D | $12,5M | $1,01 | — | $1M | -%2.344,6 |
| INTS | INTENSITY THERAPEUTICS, INC. | notsuz | $12,4M | $3,80 | — | — | — |
| TPST | Tempest Therapeutics, Inc. | notsuz | $12,3M | $0,83 | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | $12,1M | $0,27 | — | $2,5M | -%2.702,6 |
| BIVI | BioVie Inc. | notsuz | $12,1M | $1,61 | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | $11,9M | $0,78 | — | $1,4M | -%804,4 |
| INAB | IN8BIO, INC. | notsuz | $11,8M | $1,20 | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | $11,7M | $0,60 | — | $0,00 | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | $11,6M | $2,63 | — | $0,00 | — |
| BLRX | BioLineRx Ltd | C- | $11,3M | $2,60 | — | $1,2M | -%171,7 |
| GDTC | CytoMed Therapeutics Limited | D- | $11,3M | $0,96 | — | $253,9K | -%1.227,1 |
| ADIL | Adial Pharmaceuticals, Inc. | notsuz | $11,1M | $4,22 | — | — | — |
| MTVA | METAVIA INC. | notsuz | $10,9M | $1,66 | — | — | — |
| SNTI | Senti Biosciences Holdings, Inc. | F- | $10,3M | $0,33 | — | $22K | -%225.290,9 |
| TOVX | Theriva Biologics, Inc. | notsuz | $10,1M | $0,22 | — | — | — |
| IMRN | IMMURON LIMITED | D- | $9,4M | $1,16 | — | $5,1M | -%71,6 |
| FBLG | FibroBiologics, Inc. | notsuz | $9,3M | $1,39 | — | — | — |
| KALA | KALA BIO, INC. | F | $9,2M | $0,48 | — | $0,00 | — |
| VRAX | Virax Biolabs Group Ltd | C- | $8,9M | $2,40 | — | $6,3K | -%95.739,2 |
| ALZN | ALZAMEND NEURO, INC. | notsuz | $8,8M | $1,83 | — | — | — |
| TRAW | Traws Pharma, Inc. | C- | $8,7M | $0,56 | — | $2,8M | -%773,0 |
| SNGX | SOLIGENIX, INC. | D- | $8,4M | $0,38 | — | $119,4K | -%8.577,8 |
| ENSC | ENSYSCE BIOSCIENCES, INC. | D- | $8M | $0,41 | — | $4,5M | -%280,5 |
| XCUR | EXICURE, INC. | F | $8M | $1,22 | — | $0,00 | — |
| IMNN | Imunon, Inc. | notsuz | $7,9M | $1,41 | — | — | — |
| ALLR | Allarity Therapeutics, Inc. | B- | $7,9M | $1,03 | — | $320K | -%3.854,4 |
| ARTL | ARTELO BIOSCIENCES, INC. | notsuz | $7,9M | $4,54 | — | — | — |
| CBUS | Cibus, Inc. | C- | $7,6M | $1,52 | — | $4,3M | -%2.258,9 |
| ACXP | Acurx Pharmaceuticals, Inc. | notsuz | $7,2M | $1,36 | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | D- | $6,9M | $3,58 | — | $4,7M | -%611,5 |
| CELZ | Creative Medical Technology Holdings, Inc. | D- | $6,8M | $1,03 | — | $3K | -%201.355,4 |
| ENVB | ENVERIC BIOSCIENCES, INC. | notsuz | $6,7M | $1,50 | — | — | — |
| PULM | PULMATRIX, INC. | B- | $5,9M | $1,61 | — | $7,8M | -%51,4 |
| CDIO | Cardio Diagnostics Holdings, Inc. | C- | $5,8M | $1,95 | — | $14,5K | -%44.771,8 |
| AGMB | AgomAb Therapeutics NV | notsuz | $5,7M | $10,51 | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | B- | $5,6M | $3,45 | — | $582K | -%2.106,0 |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | $5,6M | $2,39 | — | $3,3M | -%75,9 |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | $5,4M | $1,55 | — | $1,5M | -%558,6 |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | $5,2M | $2,20 | — | $451K | -%1.545,2 |
| PCSA | Processa Pharmaceuticals, Inc. | notsuz | $5,1M | $1,84 | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | $4,7M | $0,44 | — | $0,00 | — |
| PHIO | PHIO PHARMACEUTICALS CORP. | notsuz | $4,6M | $1,01 | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | notsuz | $4,6M | $1,14 | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | $4,5M | $3,65 | — | $36K | -%22.448,4 |
| GRI | GRI BIO, INC. | notsuz | $4,5M | $2,05 | — | — | — |
| QNTM | Quantum BioPharma Ltd. | notsuz | $4,4M | $3,85 | — | — | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | $4,1M | $1,17 | — | $1,1M | -%729,9 |
| CVKD | Cadrenal Therapeutics, Inc. | notsuz | $4,1M | $1,15 | — | — | — |
| OSRH | OSR HEALTH, INC. | D- | $4,1M | $0,12 | — | $1,8M | -%824,4 |
| EVGN | EVOGENE LTD. | D- | $3,6M | $0,42 | — | $1,3M | -%649,2 |
| HCWB | HCW Biologics Inc. | B- | $3,5M | $1,93 | — | $6,7M | -%83,8 |
| MBIO | MUSTANG BIO, INC. | notsuz | $3,5M | $0,52 | — | — | — |
| REVB | REVELATION BIOSCIENCES, INC. | notsuz | $3,5M | $0,87 | — | — | — |
| HLSQ | BiomX Inc. | notsuz | $3,4M | $0,53 | — | — | — |
| APVO | Aptevo Therapeutics Inc. | notsuz | $3,4M | $1,89 | — | — | — |
| PBM | PSYENCE BIOMEDICAL LTD | notsuz | $3,1M | $5,56 | — | — | — |
| AZTR | Azitra, Inc. | F- | $2,9M | $0,17 | — | $0,00 | — |
| SILO | SILO PHARMA, INC. | F- | $2,8M | $1,75 | — | $54,1K | -%8.269,5 |
| TCRT | Alaunos Therapeutics, Inc. | D- | $2,8M | $1,09 | — | $3K | -%133.666,7 |
| GNPX | Genprex, Inc. | D | $2,7M | $3,29 | — | $0,00 | — |
| GOVX | GEOVAX LABS, INC. | D | $2,6M | $0,35 | — | $0,00 | — |
| VBIO | Valion Bio, Inc. | F- | $2,2M | $3,03 | — | $482K | -%3.890,0 |
| OGEN | ORAGENICS, INC. | notsuz | $2,2M | $0,49 | — | — | — |
| AIM | AIM IMMUNOTECH INC. | D | $2,1M | $0,19 | — | $95K | -%15.021,1 |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | $2,1M | $2,67 | — | $21,8K | -%42.206,9 |
| DCOY | Decoy Therapeutics Inc. | notsuz | $2M | $3,09 | — | — | — |
| SPRC | SCISPARC LTD. | F- | $1,9M | $5,21 | — | $856K | -%1.422,8 |
| CANF | Can-Fite BioPharma Ltd. | F- | $1,8M | $2,16 | — | $405K | -%2.426,7 |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | notsuz | $1,8M | $1,67 | — | — | — |
| CRIS | CURIS, INC. | F- | $1,7M | $0,83 | — | $4,3M | -%490,3 |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | notsuz | $1,6M | $1,69 | — | — | — |
| BBLG | BONE BIOLOGICS CORPORATION | notsuz | $1,4M | $0,50 | — | — | — |
| ONCO | Onconetix, Inc. | D- | $1,2M | $1,03 | — | $645,8K | -%1.578,8 |
| VIVS | VivoSim Labs, Inc. | D | $1,2M | $0,22 | — | $112K | -%11.016,1 |
| CLDI | Calidi Biotherapeutics, Inc. | notsuz | $1,2M | $1,13 | — | — | — |
| QNRX | Quoin Pharmaceuticals Ltd. | notsuz | $1,1M | $6,43 | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | notsuz | $1M | $0,16 | — | — | — |
| CMND | Clearmind Medicine Inc. | notsuz | $933,2K | $0,80 | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | notsuz | $708,3K | $0,63 | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | notsuz | $573,4K | $11,22 | — | — | — |
| PLRZ | Polyrizon Ltd. | notsuz | $488,7K | $10,78 | 2,20 | — | — |
| EDVA | SPLASH BEVERAGE GROUP, INC. | D | $408,6K | $0,19 | — | $32,1K | -%53.856,5 |
| BDRX | Biodexa Pharmaceuticals PLC | notsuz | $370,9K | $0,68 | — | — | — |
| SLXN | SILEXION THERAPEUTICS CORP | notsuz | $131,8K | $0,26 | — | — | — |
| NEUP | Neuphoria Therapeutics Inc. | F- | $109,7K | $3,65 | — | $1,2M | -%1.145,7 |
| KPTI | Karyopharm Therapeutics Inc. | B | $41,3K | $1,62 | — | $146,6M | -%153,3 |
| CDT | CDT EQUITY INC. | notsuz | $24,3K | $0,08 | — | — | — |
| PPBT | PURPLE BIOTECH LTD. | notsuz | $362,44 | $1,51 | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | notsuz | — | $19,35 | — | — | — |
| APGE | Apogee Therapeutics, Inc. | notsuz | — | $135,07 | — | — | — |
| ATAI | AtaiBeckley Inc. | notsuz | — | $7,35 | — | $4,1M | -%16.142,0 |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | $0,74 | — | $0,00 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | $84,95 | — | $42,2M | -%1.189,9 |
| ETRA | Electra Therapeutics, Inc. | notsuz | — | $11,55 | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | notsuz | — | $76,99 | — | — | — |
| SLBT | SL Science Holding Limited | notsuz | — | $1,57 | — | — | — |
| VCRE | Vicore Pharma Holding AB | notsuz | — | $9,65 | — | — | — |
| VRXA | Veraxa Biotech Holding AG | notsuz | — | $1,41 | — | — | — |
| VTVT | vTv Therapeutics Inc. | D- | — | $30,21 | — | $36,8M | -%12,9 |
Temeller SEC belgelerinden, fiyatlar son piyasa verisi taramasından. İstediğiniz sütuna göre sıralayın; rakamı olmayan şirketler her iki yönde de sona düşer.
Piyasa değerine göre büyükten küçüğe sıralı; yeniden sıralamak için herhangi bir sütuna tıklayın. Rakamı olmayan şirketler her iki yönde de sona düşer, çünkü eksik bir F/K ucuzluk değil zarar demektir. Buradaki hiçbir şey bir öneri değildir.